Markley Rehabilitation And Healthcare Center | |
550 East Fornance Street, Norristown, Pennsylvania 19401 | |
(610) 272-5600 | |
Name | Markley Rehabilitation And Healthcare Center |
---|---|
Location | 550 East Fornance Street, Norristown, Pennsylvania |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 121 |
Occupancy Rate | 73.39% |
Medicare ID (CCN) | 395483 |
Legal Business Name | Markley Operator Llc |
Ownership Type | Non Profit - Corporation |
NPI Number | 1033721410 |
Organization Name | MARKLEY OPERATOR, LLC |
Doing Business As | MARKLEY REHABILITATION AND HEALTHCARE CENTER |
Address | 550 E Fornance St, Norristown, PA 19401 |
Phone Number | 732-903-1971 |
News Archive
A study published in the January 1 issue of the journal SLEEP finds that people with untreated obstructive sleep apnea (OSA) have altered cardiovascular responses during recovery from maximal exercise.
In his latest Foreign Policy column, Charles Kenny, a senior fellow at the Center for Global Development, argues that famine is a crime.
Researchers from Columbia University, with colleagues at Genia Technologies, Harvard University and the National Institute of Standards and Technology report achieving real-time single molecule electronic DNA sequencing at single-base resolution using a protein nanopore array.
IMPAX Laboratories, Inc. today announced Purdue Pharma Products L.P. ("Purdue"), Napp Pharmaceutical Group Ltd. ("Napp"), Biovail Laboratories International, SRL ("Biovail") and Ortho-McNeil, Inc. ("Ortho-McNeil") have filed suit for patent infringement in the United States District Court for the District of Delaware based on the Company's submission of its Abbreviated New Drug Application ("ANDA") for tramadol hydrochloride extended-release tablets (100 mg), generic of Ultram ER, to the Food and Drug Administration.
A biosimilar protein that can be used to treat neutropenia (a side effect of cancer chemotherapy) is to be developed by Apotex Inc. of Canada in collaboration with Intas Biopharmaceuticals Limited (IBPL).
› Verified 4 days ago
NPI Number | 1700900339 |
Organization Name | GENESIS |
Address | 550 E Fornance St, Norristown, PA 19401 |
Phone Number | 610-272-5600 |
News Archive
A study published in the January 1 issue of the journal SLEEP finds that people with untreated obstructive sleep apnea (OSA) have altered cardiovascular responses during recovery from maximal exercise.
In his latest Foreign Policy column, Charles Kenny, a senior fellow at the Center for Global Development, argues that famine is a crime.
Researchers from Columbia University, with colleagues at Genia Technologies, Harvard University and the National Institute of Standards and Technology report achieving real-time single molecule electronic DNA sequencing at single-base resolution using a protein nanopore array.
IMPAX Laboratories, Inc. today announced Purdue Pharma Products L.P. ("Purdue"), Napp Pharmaceutical Group Ltd. ("Napp"), Biovail Laboratories International, SRL ("Biovail") and Ortho-McNeil, Inc. ("Ortho-McNeil") have filed suit for patent infringement in the United States District Court for the District of Delaware based on the Company's submission of its Abbreviated New Drug Application ("ANDA") for tramadol hydrochloride extended-release tablets (100 mg), generic of Ultram ER, to the Food and Drug Administration.
A biosimilar protein that can be used to treat neutropenia (a side effect of cancer chemotherapy) is to be developed by Apotex Inc. of Canada in collaboration with Intas Biopharmaceuticals Limited (IBPL).
› Verified 4 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
A study published in the January 1 issue of the journal SLEEP finds that people with untreated obstructive sleep apnea (OSA) have altered cardiovascular responses during recovery from maximal exercise.
In his latest Foreign Policy column, Charles Kenny, a senior fellow at the Center for Global Development, argues that famine is a crime.
Researchers from Columbia University, with colleagues at Genia Technologies, Harvard University and the National Institute of Standards and Technology report achieving real-time single molecule electronic DNA sequencing at single-base resolution using a protein nanopore array.
IMPAX Laboratories, Inc. today announced Purdue Pharma Products L.P. ("Purdue"), Napp Pharmaceutical Group Ltd. ("Napp"), Biovail Laboratories International, SRL ("Biovail") and Ortho-McNeil, Inc. ("Ortho-McNeil") have filed suit for patent infringement in the United States District Court for the District of Delaware based on the Company's submission of its Abbreviated New Drug Application ("ANDA") for tramadol hydrochloride extended-release tablets (100 mg), generic of Ultram ER, to the Food and Drug Administration.
A biosimilar protein that can be used to treat neutropenia (a side effect of cancer chemotherapy) is to be developed by Apotex Inc. of Canada in collaboration with Intas Biopharmaceuticals Limited (IBPL).
› Verified 4 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 3 |
Total Amount of Fines in Dollars | $182671 |
Number of Payment Denials | 0 |
Total Number of Penalties | 3 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 9.7 | 14.46 |
Percentage of long-stay residents who lose too much weight | 9.79 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 58.49 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.35 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.63 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.96 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 6.01 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 19.38 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 83.91 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 5.13 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 19.67 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.04 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 5.75 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.58 | 95.98 |